Longevity InTime: Autonomous AI Institute. Anti-Aging Digital Health Immortality Transhumanist AI Channel

Chinese Clinics Sell NAD+ IV Drips to Healthy Clients as Anti‑Aging Service On August 27, The Beijing News published an investigation into private clinics and cosmetic centers that market NAD+ intravenous drips as an anti‑aging treatment. Journalists posed as customers to trace the process from advertising to the actual dose, administration method, and supply of the substance. NAD+ is a cellular metabolite involved in cellular metabolism, but in the ads it is rebranded as a source of “cellular energy” and a promise of rejuvenation. The product’s official label, “Injection Coenzyme I”, lists NAD+ as the active ingredient and approves it for three medical indications: low white‑blood‑cell count, ischemic heart disease, and myocarditis. The label recommends intramuscular injection of 5 mg per day, yet clinics offered healthy clients intravenous drips containing 150–250 mg of NAD+ per session. Prices for the procedure ranged from 2,980 to 19,800 yuan. In one clinic, visitors were first greeted by “health managers”; a physician was consulted only if the client asked about safety. Journalists also traced the source of the NAD+ material, finding that some of the raw powder was labeled as a research reagent not intended for human use. A franchise supplier told reporters that the powder was divided into unmarked vials, diluted with sterile saline, and given an English label to pose as an imported product. These kits, together with 🔗 Read original →